Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization

Journal of Pediatric Surgery

Volumn 37, Issue 12, 2002, Pages 1747-1750

  Fukuzawa, Masahiro ^a,b   Sugiura, Hiroaki ^a,b   Koshinaga, Tsugumichi ^a,b   Ikeda, Taro ^a,b   Hagiwara, Noritugu ^a,b   Sawada, Tatsuo ^a,b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Women's Medical University   (Japan)

Author keywords

Angiogenesis; F; k 1; Neuroblastoma; Vascular endothelial growth factor

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CANCER INVASION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0036894805     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2002.36712     Document Type: Conference Paper

References (20)

1. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
2. Gaudin PB, Rosai J: Florid vascular proliferation associated with neural and neuroendocrine neoplasms. J Am Surg Pathol 19:642-652, 1995
3. Folkmann J: Anti-angiogenesis. New concept for therapy of solid tumors. Ann Surg 175:409-416, 1972
4. Nagabuchi E, WanderKolk WE, Une Y, et al: TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J Pediatr Surg 32:287-293, 1997
5. Senger DR, VandeWater L, Brown LF, et al: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303-324, 1993
6. Tischer E, Mitchell R, Hartman T, et al: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954, 1991
7. Terman BI, Carrion MN, Kovacs E, et al: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683, 1991
8. Hashimoto M, Ohsawa M, Ohnishi A, et al: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 73:859-863, 1993
9. Langer I, Vertongen P, Perret J, et al: Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastoma. Med Pediatr Oncol 34:386-393, 2000
10. Meister B, Grunebach F, Bautz F, et al: Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer 35:445-449, 1999
11. Butler K, Zorn AM, Gurdon JB: Nonradioactive in situ hybridization to xenopus tissue sections. Methods 23:303-312, 2001
12. Matthay KK: Neuroblastoma: A clinical challenge and biologic puzzle. CA Cancer J Clin 45:179-192, 1995
13. Folkmann J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65-71, 1992
14. Meitar D, Crawfold SE, Rademaker AW, et al: Tumor angiogenesis with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 14:405-414, 1996
15. Waltenberger J, Claesson-Welsh L, Siegbahn A, et al: Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 296:26988-26995, 1994
16. Nagabuchi E, VanderKolk WE, Une Y, et al: TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J Pediatr Surg 32:287-293, 1997
17. Wassberg E, Christofferson R: Angiostatic treatment of neuroblastoma. Eur J Cancer 33:2020-2023, 1997
18. Wassberg E, Pahlman S, Westlin J, et al: The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr Res 41:327-333, 1997
19. Fong TA, Shawver LK, Sun L, et al: SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple types. Cancer Res 59:99-106, 1999
20. Davidoff, Leary MA, Ng CYC, et al: Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo. J Pediatr Surg 36:30-36, 2001